Full text is available at the source.
Abstract
Subcutaneous semaglutide is associated with significant weight loss and improvements in cardiometabolic risk factors.
- Obesity is a chronic condition linked to several serious health issues.
- Semaglutide has proven to be an effective medication for managing obesity.
- The review focused on adults with overweight or obesity who do not have diabetes.
- Efficacy and safety of semaglutide were assessed through systematic review and meta-analysis.
Simplified